3,3’-Diindolylmethane and its derivatives: nature-inspired strategies tackling drug resistant tumors by regulation of signal transduction, transcription factors and microRNAs

Bernhard Biersack

Cancer Drug Resistance ›› 2020, Vol. 3 ›› Issue (4) : 867 -878.

PDF
Cancer Drug Resistance ›› 2020, Vol. 3 ›› Issue (4) :867 -878. DOI: 10.20517/cdr.2020.53
Review
review-article

3,3’-Diindolylmethane and its derivatives: nature-inspired strategies tackling drug resistant tumors by regulation of signal transduction, transcription factors and microRNAs

Author information +
History +
PDF

Abstract

Indoles of cruciferous vegetables are promising anti-tumor agents. Studies with indole-3-carbinol and its dimeric product, 3,3’-diindolylmethane (DIM), suggest that these compounds have the ability to deregulate multiple cellular signaling pathways that are essential for tumor growth and spread. These natural compounds are also effective modulators of transcription factors and non-coding RNAs. These effects explain their ability to inhibit tumor spread and to overcome drug resistance. In this work, pertinent literature on the effects of DIM and its synthetic derivatives on resistant tumors and resistance mechanisms in tumors is highlighted.

Keywords

Indole / 3 / 3’-diindolylmethane / drug resistance / anticancer drugs / microRNAs

Cite this article

Download citation ▾
Bernhard Biersack. 3,3’-Diindolylmethane and its derivatives: nature-inspired strategies tackling drug resistant tumors by regulation of signal transduction, transcription factors and microRNAs. Cancer Drug Resistance, 2020, 3(4): 867-878 DOI:10.20517/cdr.2020.53

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Urruticoechea A,Balart J,Vinals F.Recent advances in cancer therapy: an overview..Curr Pharm Des2010;16:3-10

[2]

Baskar R,Yeo R.Cancer and radiation therapy: current advances and future directions..Int J Med Sci2012;9:193-9 PMCID:PMC3298009

[3]

Khalil DN,Brentjens RJ.The future of cancer treatment: immunomodulation, CARs and combination immunotherapy..Nat Rev Clin Oncol2016;13:273-90 PMCID:PMC5551685

[4]

Wang X,Chen X.Drug resistance and combating drug resistance in cancer..Cancer Drug Resist2019;2:141-60

[5]

Kumar S,Gupta S.Emerging targets in cancer drug resistance..Cancer Drug Resist2019;2:161-77

[6]

Johnson IS,Gorman M.The Vinca alkaloids: a new class of oncolytic agents..Cancer Res1963;23:1390-427

[7]

Biersack B.Indole compounds against breast cancer: recent developments..Curr Drug Targets2012;13:1705-19

[8]

Omura S,Hirano A,Awaya J.A new alkaloid AM-2282 of Streptomyces origin. Taxonomy, fermentation, isolation and preliminary characterization..J Antibiot1977;30:275-82

[9]

Oudard S,Decoene J.Sunitinib for the treatment of metastatic renal cell carcinoma..Cancer Treat Rev2011;37:178-84

[10]

Bourhill T,Johnston RN.Enzastaurin: a lesson in drug development..Crit Rev Oncol Hematol2017;112:72-9

[11]

Sarkar FH.Harnessing the fruits of nature for the development of multi-targeted cancer therapeutics..Cancer Treat Rev2009;35:597-607 PMCID:PMC2784186

[12]

Ahmad A,Li Y,Bao B.Target regulation of PI3K/Akt/mTOR/NF-kB signaling by indole compounds and their derivatives: mechanistic details and biological implications for cancer therapy..Anti-Cancer Agents Med Chem2013;13:1002-13 PMCID:PMC3901097

[13]

Ahmad A,Rahman KM.Anticancer properties of indole compounds: mechanism of apoptosis induction and role in chemotherapy..Cancer Treat Rev2009;35:597-607

[14]

Terry P,Persson I.Brassica vegetables and breast cancer risk..JAMA2001;285:2975-7

[15]

Keck AS.Cruciferous vegetables: cancer protective mechanisms of glucosinolate hydrolysis products and selenium..Integr Cancer Ther2004;3:5-12

[16]

Paltsev M,Muyzhnek E,Kuznetsov I.Comparative preclinical pharmacokinetics study of 3,3’-diindolylmethane formulations: is personalized treatment and targeted chemoprevention in the horizon?.EPMA J2013;4:25 PMCID:PMC4029298

[17]

Kaishap PP.Synthetic approaches for bis(indolyl)methanes..Int J Pharm Sci Res2013;4:1312-22

[18]

Shiri M,Kruger HG.Bis- and trisindolylmethanes (BIMs and TIMs)..Chem Rev2010;110:2250-93

[19]

Safe S,Chintharlapalli S.Cancer chemotherapy with indole-3-carbinol, bis(3’-indolyl)methane and synthetic analogs..Cancer Lett2008;269:326-38 PMCID:PMC2574232

[20]

Li Y,Ahmad A,Sarkar FH.Antioxidant function of isoflavone and 3,3’-diindolylmethane: are they important for cancer prevention and therapy..Antioxid Redox Signal2013;19:139-50 PMCID:PMC3689155

[21]

Popolo A,Daglia M,Farooqi AA.Two likely targets for the anti-cancer effect of indole derivatives from cruciferous vegetables: PI3K/Akt/mTOR signaling pathway and the aryl hydrocarbon receptor..Seminars Cancer Biol2017;46:132-7

[22]

Wang S,Liu Y,Jiang W.Indole-3-carbinol (I3C) and its major derivatives: their pharmacokinetics and important roles in hepatic protection..Curr Drug Metabol2016;17:401-9

[23]

Reed GA,Sullivan DK,Mayo MS.Single-dose pharmacokinetics and tolerability of absorption-enhanced 3,3’-diindolylmethane in healthy subjects..Cancer Epidemiol Biomarkers Prev2008;17:2619-24 PMCID:PMC2602858

[24]

Amare DE.Anti-cancer and other biological effects of a dietary compound 3,3’-diindolylmethane supplementation: a systematic review of human clinical trials..Nutr Diet Suppl2020;12:123-37

[25]

Heath EI,Li J,Harper F.A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3’-Diindolylmethane) in castrate-resistant, non-metastatic prostate cancer..Am J Transl Res2010;2:402-11 PMCID:PMC2923864

[26]

Hwang C,Heilbrun LK,Chitale DA.Anti-androgenic activity of absorption-enhanced 3,3’-diindolylmethane in prostatectomy patients..Am J Transl Res2016;8:166-76 PMCID:PMC4759426

[27]

Gee JR,Messing E,Kolesar J.Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomy..Eur J Cancer Prev2016;25:312-20

[28]

Thomson CA,Wertheim BC,Stopeck A.A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen..Breast Cancer Res Treat2017;165:97-107 PMCID:PMC5571834

[29]

Biersack B.Non-coding RNA/microRNA-modulatory dietary factors and natural products for improved cancer therapy and prevention: alkaloids, organosulfur compounds, aliphatic carboxylic acids and water-soluble vitamins..Non-Coding RNA Res2016;1:51-63 PMCID:PMC6096427

[30]

Kong D,Chen W,Powell I.Loss of let-7 upregulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIM..PLoS One2012;7:e33729 PMCID:PMC3307758

[31]

Kashat M,Sarkar SH,Li Y.Inactivation of AR and Notch-1 signaling by miR-34a attenuates prostate cancer aggressiveness..Am J Transl Res2012;4:432-42 PMCID:PMC3493023

[32]

Yu J,Wang Y.Aryl hydrocarbon receptor enhances the expression of miR-150-5p to suppress in prostate cancer progression by regulating MAP3K12..Arch Biochem Biophys2018;654:47-54

[33]

Ahmad A,Ahmed A,Raz A.Diindolylmethane enhances the effectiveness of Herceptin against HER-2/neu-expressing breast cancer cells..PLoS One2013;8:e54657 PMCID:PMC3551844

[34]

Hanieh H.Aryl hydrocarbon receptor-microRNA-212/132 axis in human breast cancer suppresses metastasis by targeting SOX4..Mol Cancer2015;14:172 PMCID:PMC4573482

[35]

Li Y,Kong D,Ali S.Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells..Cancer Res2009;69:6704-12 PMCID:PMC2727571

[36]

Li Y,Wang Z,Ali S.MiR-146a suppresses invasion of pancreatic cancer cells..Cancer Res2010;70:1486-95 PMCID:PMC2978025

[37]

Li Y,Ahmad A,Sarkar FH.Targeting bone remodeling by isoflavone and 3,3’-diindolylmethane in the context of prostate cancer bone metastasis..PLoS One2012;7:e33011 PMCID:PMC3296768

[38]

Sarkar S,Ali S,Kollepara SL.Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57 (kip2), and PUMA..Am J Cancer Res2013;3:465-77 PMCID:PMC3816966

[39]

Jin Y.3,3’-Diindolylmethane inhibits breast cancer cell growth via miR-21-mediated CDC25A degradation..Mol Cell Biochem2011;358:345-54

[40]

Junaid M,Islam N,Alam MJ.Molecular simulation studies of 3,3’-diindolylmethane as a potent microRNA-21 antagonist..J Pharm Bioallied Sci2017;9:259-65 PMCID:PMC5810076

[41]

Bhowmik A,Pal U,Bhattacharya S.2,2’-Diphenyl-3,3’-diindolylmethane: a potent compound induces apoptosis in breast cancer cells by inhibiting EGFR pathway..PLoS One2013;8:e59798 PMCID:PMC3610887

[42]

Abdelbaqi K,Guns ET,Safe S.Antiandrogenic and growth inhibitory effects of ring-substituted analogs of 3,3’-diindolylmethane (ring-DIMs) in hormone-responsive LNCaP human prostate cancer cells..Prostate2011;71:1401-12

[43]

Goldberg AA,Beach A,Safe S.Ring-substituted analogs of 3,3’-diindolylmethane (DIM) induce apoptosis and necrosis in androgen-dependent and -independent prostate cancer cells..Invest New Drugs2014;32:25-36 PMCID:PMC4841686

[44]

Draz H,Titorenko VI,Safe S.Diindolylmethane and its halogenated derivatives induce protective autophagy in human prostate cancer cells via induction of the oncogenic protein AEG-1 and activation of AMP-activated protein kinase..Cell Signal2017;40:172-82

[45]

Chintharlappali S,Safe S.1,1-Bis(3’-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through PPARgamma-dependent and PPARgamma-independent pathways..Mol Cancer Ther2006;5:1362-70

[46]

Yoon K,Cho SD,Kham S.Activation of nuclear TR3 (NR4A1) by a diindolylmethane analog induces apoptosis and proapoptotic genes in pancreatic cancer cells and tumors..Carcinogenesis2011;32:836-42 PMCID:PMC3106434

[47]

Hedrick E,Lacey A,Zarel M.Potent inhibition of breast cancer by bis-indole-derived nuclear receptor 4A1 (NR4A1) antagonists..Breast Cancer Res Treat2019;177:29-40 PMCID:PMC6681651

[48]

Li X,Shrestha R.Structure-dependent activation of gene expression by bis-indole and quinolone-derived activators of nuclear receptor 4A2..Chem Biol Drug Des2019;94:1711-20 PMCID:PMC6791730

[49]

Boakye CHA,Patel AR,Zuculotto V.Lipid-based oral delivery systems for skin deposition of a potential chemopreventive DIM derivative: characterization and evaluation..Drug Deliv Transl Res2016;6:526-39

[50]

Yoon K,Orr AA,Tamamis P.Activation of Coup-TFI by a novel diindolylmethane derivative..Cells2019;220: PMCID:PMC6468570

[51]

Klinge CM,Driscoll MD,Bambara RA.Chicken ovalbumin upstream promoter-transcription factor interacts with estrogen receptor response elements and half-sites, and inhibits estrogen-induced gene expression..J Biol Chem1997;272:31465-74

[52]

Le Dily F,Gueguen MM,Flouriot G.COUP-TFI modulates estrogen signaling and influences proliferation, survival and migration of breast cancer cells..Breast Cancer Res Treat2008;110:69-83

[53]

Muenzner JK,Rothemund M,Padhye S.Ferrocene-substituted 3,3’-diindolylmethanes with improved anticancer activity..Appl Organometal Chem2016;30:441-5

[54]

Ahmad A,Schruefer S,Sarkar FH.Pentafluorophenyl substitution of natural di(indolyl-3-yl)methane strongly enhances growth inhibition and apoptosis induction in various cancer cell lines..Chem Biodiversity2019;16:e1900028

[55]

Dankhoff K,Weber B,Schobert R.Anticancer properties of a new non-oxido vanadium(IV) complex with a catechol-modified 3,3’-diindolylmethane ligand..J Inorg Biochem2019;194:1-6

[56]

Chakraborty S,Banerjee B,Adhikary A.Phemindole, a synthetic di-indole derivative maneuvers the store operated calcium entry (SOCE) to induce potent anti-carcinogenic activity in human triple negative breast cancer cells..Front Pharmacol2016;7:114 PMCID:PMC4854895

[57]

Patel AR,Wilson H,Singh M.Evaluation of spray BIO-Max DIM-P in dogs for oral bioavailability and in Nu/nu mice bearing orthotopic/metastatic lung tumor models for anticancer activity..Pharm Res2015;32:2292-300 PMCID:PMC5725226

[58]

Godugu C,Safe SH.Novel diindolylmethane derivatives based NLC formulations to improve the oral bioavailability and anticancer effects in triple negative breast cancer..Eur J Pharm Biopharm2016;108:168-79 PMCID:PMC5725228

[59]

Patel AR,Andey T,Safe S.Evaluation of self-emulsified DIM-14 in dogs for oral bioavailability and in Nu/nu mice bearing stem cell lung tumor models for anticancer activity..J Controlled Release2015;213:18-26 PMCID:PMC5645071

[60]

Sharma DK,Lambu MR,Yousuf SK.Design and synthesis of novel N,N’-glycoside derivatives of 3,3’-diindolylmethanes as potential antiproliferative agents..Med Chem Commun2012;3:1082-91

[61]

Nayak D,Rah B,Rasool RU.Synthesis, pharmacodynamics and pharmacokinetic evaluation of a novel, therapeutically relevant N-glycosylated derivative of DIM (NGD16) as potential inhibitor of angiogenesis..J Cancer Sci Ther2014;6:278-88

[62]

Katoch A,Chakraborty S,Rasool RU.Dual role of Par-4 in abrogation of EMT and switching on mesenchymal to epithelial transition (MET) in metastatic pancreatic cancer cells..Mol Carcinogenesis2018;57:1102-15

[63]

Li WS,Ko S,Jen YC.Synthesis and evaluation of the cytotoxicities of tetraindoles: observation that the 5-hydroxy tetraindole (SK228) induces G2 arrest and apoptosis in human breast cancer cells..J Med Chem2012;55:1583-92

[64]

Chao WR,Amin K,Jong L.Computer-aided rational drug design: a novel agent (SR13668) designed to mimic the unique anticancer mechanisms of dietary indole-3-carbinol to block Akt signaling..J Med Chem2007;50:3412-5

[65]

Ahmed EM,El-Naggar DH,El-Naggar M.Towards breast cancer targeting: synthesis of tetrahydroindolocarbazoles, antibreast cancer evaluation, uPA inhibition, molecular genetic and molecular modelling studies..Bioorg Chem2019;93:103332

AI Summary AI Mindmap
PDF

217

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/